Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review-Reference-Cited by-同舟云学术

Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review

Published:2020-05-27 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Bocchini Martine,Nicolini Fabio,Severi Stefano,Bongiovanni Alberto,Ibrahim Toni,Simonetti Giorgia,Grassi Ilaria,Mazza Massimiliano

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference237 articles.

1. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival;Halfdanarson;Ann Oncol.,2008

2. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united states;Dasari;JAMA oncology.,2017

3. Gastroenteropancreatic neuroendocrine tumours;Modlin;Lancet Oncol.,2008

4. Hereditary neuroendocrine tumors of the gastroenteropancreatic system;Anlauf;Virchows Arch.,2007

5. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-Functional pancreatic neuroendocrine tumors;Falconi,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM;Radiology and Oncology;2023-11-30

2. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective;Current Treatment Options in Oncology;2023-11-22

3. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment;Medicine;2023-11-17

4. Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance—A Retrospective, Long-Term Single-Center Experience;Cancers;2023-08-29

5. Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors;Frontiers in Oncology;2023-05-23